IMNM
Price
$9.52
Change
-$0.59 (-5.84%)
Updated
Feb 21 closing price
Capitalization
806.11M
32 days until earnings call
KYTX
Price
$2.78
Change
-$0.06 (-2.11%)
Updated
Feb 21 closing price
Capitalization
120.02M
38 days until earnings call
Ad is loading...

IMNM vs KYTX

Header iconIMNM vs KYTX Comparison
Open Charts IMNM vs KYTXBanner chart's image
Immunome
Price$9.52
Change-$0.59 (-5.84%)
Volume$674.08K
Capitalization806.11M
Kyverna Therapeutics
Price$2.78
Change-$0.06 (-2.11%)
Volume$347.62K
Capitalization120.02M
IMNM vs KYTX Comparison Chart
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. KYTX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Hold and KYTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (IMNM: $9.52 vs. KYTX: $2.78)
Brand notoriety: IMNM and KYTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 67% vs. KYTX: 88%
Market capitalization -- IMNM: $806.11M vs. KYTX: $120.02M
IMNM [@Biotechnology] is valued at $806.11M. KYTX’s [@Biotechnology] market capitalization is $120.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileKYTX’s FA Score has 0 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • KYTX’s FA Score: 0 green, 5 red.
According to our system of comparison, IMNM is a better buy in the long-term than KYTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 3 TA indicator(s) are bullish while KYTX’s TA Score has 5 bullish TA indicator(s).

  • IMNM’s TA Score: 3 bullish, 6 bearish.
  • KYTX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, KYTX is a better buy in the short-term than IMNM.

Price Growth

IMNM (@Biotechnology) experienced а -8.46% price change this week, while KYTX (@Biotechnology) price change was -8.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

IMNM is expected to report earnings on May 08, 2025.

KYTX is expected to report earnings on Apr 01, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($806M) has a higher market cap than KYTX($120M). IMNM YTD gains are higher at: -10.358 vs. KYTX (-25.668). KYTX (-108.46M) and IMNM (-109.95M) have comparable annual earnings (EBITDA) . KYTX has more cash in the bank: 322M vs. IMNM (240M). IMNM has less debt than KYTX: IMNM (2.72M) vs KYTX (9.14M). IMNM has higher revenues than KYTX: IMNM (10.1M) vs KYTX (0).
IMNMKYTXIMNM / KYTX
Capitalization806M120M672%
EBITDA-109.95M-108.46M101%
Gain YTD-10.358-25.66840%
P/E RatioN/AN/A-
Revenue10.1M0-
Total Cash240M322M75%
Total Debt2.72M9.14M30%
TECHNICAL ANALYSIS
Technical Analysis
IMNMKYTX
RSI
ODDS (%)
Bullish Trend 5 days ago
87%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
57%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend about 1 month ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIREX29.13N/A
N/A
Principal Real Estate Securities Inst
ETLNX14.51N/A
N/A
Eventide Large Cap Focus N
FIVLX11.03N/A
N/A
Fidelity International Value
PRPCX5.11N/A
N/A
PGIM Jennison Energy Infrastructure C
ESCGX10.75N/A
N/A
Ashmore Emerging Markets Equity ESG C

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KYMR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-5.84%
KYMR - IMNM
49%
Loosely correlated
-1.63%
IDYA - IMNM
49%
Loosely correlated
+0.55%
FATE - IMNM
48%
Loosely correlated
-8.09%
RXRX - IMNM
47%
Loosely correlated
-10.34%
BEAM - IMNM
47%
Loosely correlated
-8.18%
More

KYTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYTX has been loosely correlated with CABA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if KYTX jumps, then CABA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYTX
1D Price
Change %
KYTX100%
-2.11%
CABA - KYTX
47%
Loosely correlated
-1.44%
PRME - KYTX
42%
Loosely correlated
-5.27%
IMNM - KYTX
41%
Loosely correlated
-5.84%
ACLX - KYTX
40%
Loosely correlated
-2.83%
KYMR - KYTX
40%
Loosely correlated
-1.63%
More